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Abstract
Microarray-based expression profiling of living systems is a quick and inexpensive method to obtain insights into the nature
of various diseases and phenotypes. A typical microarray profile can yield hundreds or even thousands of differentially
expressed genes and finding biologically plausible themes or regulatory mechanisms underlying these changes is a non-
trivial and daunting task. We describe a novel approach for systems-level interpretation of microarray expression data using
a manually constructed ‘‘overview’’ pathway depicting the main cellular signaling channels (Atlas of Signaling). Currently,
the developed pathway focuses on signal transduction from surface receptors to transcription factors and further
transcriptional regulation of cellular ‘‘workhorse’’ proteins. We show how the constructed Atlas of Signaling in combination
with an enrichment analysis algorithm allows quick identification and visualization of the main signaling cascades and
cellular processes affected in a gene expression profiling experiment. We validate our approach using several publicly
available gene expression datasets.
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Introduction
Microarray-based expression profiling of living systems is a
quick and inexpensive method to obtain insights into the nature of
various diseases and phenotypes. It is also a great way of studying
the functions of individual proteins or drugs by looking at the
affected targets after system distrurbances or genetic modifications
(siRNA, knock-outs, gene over-expression, etc).
The greatest challenge of microarray-based expression profi-
ling is interpreting the obtained results. In a typical microarray
experiment, mRNA profiles are generated for thousands of genes
on a chip from a collection of samples derived from studied
experimental conditions. Thus, the difficulty is finding an un-
derlying biological theme or specific mechanisms hidden behind
the expression profiles. Many of the genes changed in an
experiment may fall outside the area of expertise of an individual
researcher. A common approach has always been focusing on a
handful of most highly changed probes. The main limitation of
this approach is a risk to miss small, but concerted changes in a
group of functionally related genes.
The recent advancement in interpreting the microarray data is
development of the gene set enrichment analysis (GSEA) [1]–a
statistically robust algorithm which compares the entire differential
expression profile against biologically meaningful gene sets,
defined by prior knowledge (e.g. pathways, cellular processes,
etc). The goal of the GSEA is to determine whether all members of
each gene set tend to be synchronously changed in a microarray
experiment. As a result, the microarray experiment is projected on
a much smaller list of statistically significantly changed gene sets
which can summarize the observed expressional changes on a
gene-systems level. A drawback of focusing only on highly
differentially expressed genes lies in the fact that signaling proteins
participating in the observed cellular response might not be
changed on the level of expression even though corresponding
pathways are activated or inhibited.
In this paper, we present a novel approach for analysis of
differential gene expression profiles aimed at identification of key
protein regulators and pathways involved in the differential
response. The major ideas of our approach are:
– Utilizing a gene expression regulatory network built using facts
extracted from literature to generate a comprehensive
collection of gene sets, each representing immediate down-
stream neighbors (sub-networks) of every individual protein in
the network.
– Grouping proteins into functionally coherent groups (either by
protein families performing similar functions or by participa-
tion in common cellular processes) and connecting these groups
by well-established biological regulatory links into a single
overview pathway (Atlas of Signaling) depicting main cellular
signaling channels.
– Interpreting differential gene expression by ‘‘projecting’’ sub-
networkssignificantlyenrichedwithdifferentiallyexpressedgenes
onto the Atlas of Signaling in order to identify key regulatory
proteins and pathways involved in the differential response.
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strate that this approach can successfully identify main signaling
cascades involved in the regulation of the cellular response.
Methods
All the analyses described in this paper have been performed
using PathwayStudioH software version 6.2. PathwayStudio is a
commercial product for pathway analysis which contains a
comprehensive database of protein–protein relationships extracted
from literature using MedScanH–a fully automated biomedical
information extraction engine.
An Overview of the Atlas of Signaling
The principal components of the Atlas of Signaling are protein
groups (classes) representing either protein families or molecu-
lar-level cellular processes. Conceptually, we distinguish 5 sub-
categories of proteins: ligands, receptors, signaling proteins,
transcription factors and ‘‘workhourse’’ proteins (Table 1).
Workhorse proteins are grouped into cellular processes. We
thought to develop a minimal set of ubiquitous tissue-independent
molecular events intrinsic to normal physiology of a eukaryotic
cell, e.g. actin cytoskeleton assembly, DNA replication, or
translation. More complex structural processes, such as mitosis,
apoptosis or vesicular transport can be represented in terms of
these elementary processes. For instance, the molecular events of
mitosis include chromatin condensation, spindle assembly, cen-
trosome separation, kinetochore assembly etc. The higher-level
structural process can be represented as a chain of elementary
events, each performed by a limited set of proteins-executors. The
same pertains to the majority of tissue-specific processes. For
example, the process ‘‘neurotransmitter secretion’’ describes a
neuron-specific version of secretory vesicle exocytosis. Proteins of
the SNARE complex and clathrin cage proteins comprise the
group of executors responsible for membrane budding and fusion
during various exocytosis events in different cell types. We
assigned only direct executors (‘‘workhorse proteins’’) or their
direct specific regulators to our minimal set of cellular processes:
biochemical pathways include only biochemical enzymes, trans-
port processes include only transporters, and structural processes
include structural proteins responsible for physical integrity of a
cell or its ‘‘molecular machinery’’ and their direct specific
regulators (e.g. regulatory cytoskeleton- or microtubule-associated
proteins). For instance, the ‘‘microtubule sliding’’ process contains
tubulins, kinesins, dyneins and microtubule-asociated proteins.
Cellular processes also include biochemical and transport
processes that contain major cellular biochemical pathways and
metabolite/ion transport processes respectively.
Ligands, receptors, signaling proteins, and transcription factors
are grouped into protein families based on sequence and
functional similarity. The complete list of protein groups can be
found in the supporting File S1.
We have connected protein groups by regulatory relationships
that are used to describe the signaling information flow inside the
cell. The relationships between protein classes are based on well-
established relationships between individual proteins from the two
classes (Figure 1) described in literature. There are several types of
protein relationships that were originally introduced in ResNet
database for Pathway Studio [2,3]. The complete list of
relationship types and their statistics on the Atlas of Signaling is
shown in Table 2. All relationships between functional groups can
be visualized in Pathway Studio as one big pathway that we call
the ‘‘Atlas of Signaling’’ (Figure 2). The Atlas is focused on the
transduction of signals from extracellular space through receptors
and regulatory cascades to transcription factors and further
regulation of expression of workhorse proteins. Extracellular
ligands are on the top of the map followed by the row of plasma
membrane-localized receptors. Cell processes are positioned at the
bottom, and signaling proteins and transcription factors connect
upper and lower parts of the map. The map contains 381 protein
classes and 861 relations and can be considered a ‘‘scaffold’’ map
of the main signal transduction pathways in a cell. The full list of
relationships in the Atlas of Signaling is provided in the supporting
File S2.
Protein Expression Sub-Networks as Gene Sets
One of the key ideas behind our gene expression interpretation
approach is utilization of a gene expression regulatory network
built from facts extracted from literature. The network is used to
generate a comprehensive collection of gene sets, each represent-
ing immediate downstream neighbors of each individual protein
in the network (Figure 3). We call a ‘‘center’’ protein of such
sub-network the ‘‘seed’’ protein and assume that if the downs-
tream expression targets of the seed protein are enriched with
differentially expressed genes (i.e. the sub-network is found to be
statistically significant in enrichment analysis) then the seed protein
is one of the key regulators of the observed differential response.
Since sub-networks are constructed from all the proteins in the
entire expression network, including ligands, receptors, signaling
proteins and transcription factors, the seed proteins of statistically
significant sub-networks presumably constitute the components of
a regulatory network involved in the modulation of the observed
differential response.
The gene expression regulation relationships are extracted
from PubMed abstracts and full-text papers using MedScan
technology [4,5]. They describe involvement of various proteins:
ligands, receptors, signaling proteins and transcription factors in
regulation of protein expression. The complete gene expression
regulatory network was extracted from entire 2007 PubMed
and the content of 61 freely available full-text journals and
contains 163,945 unique relationships. As noted, the extracted
relationships represent not only direct regulation of expres-
sion by transcription factors, but also indirect relationships
(e.g. ‘‘protein A regulates expression of protein B’’, and similar
statements).
In addition to expression sub-networks, the separate collection
of gene sets was constructed from the members of all the functional
groups themselves to capture the concerted changes in expression
among the members of the groups: ligands, receptors, signaling
Table 1. The main categories and subcategories of protein







Molecular function Ligands 42 444
Receptors 65 932
Signaling proteins 157 744
Transcription factors 94 1,841
Cellular Process Biochemical processes 41 1,579
Metabolite/ion transport 42 1,056
Structural processes 63 3,821
aThe complete list of protein classes can be found in supporting File S1.
doi:10.1371/journal.pone.0009256.t001
Atlas of Signaling
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‘‘groups’’–biochemical pathways, transport processes and struc-
tural processes.
Enrichment Analysis of Differential Gene Expression
Using Expression Sub-Networks and the Atlas of
Signaling
The following steps describe our approach for interpreting
differential gene expression in the context of the Atlas of Signaling
1. Differential gene expression between samples of interest is
calculated using T-test.
2. The enrichment analysis is performed for normalized log ratio
differential samples using Mann-Whitney test [6] against the
collection of gene sets generated as described above. All gene
sets with a p-value ,0.05 are considered significant and are
selected for further analysis.
3. Significant gene sets are mapped to the Atlas of Signaling
pathway as follows:
Figure 1. Reduction of a pathway complexity using Atlas of Signaling. (A) Signal transduction pathway from integrin receptors to actin
cytoskeleton built from individual proteins (red shapes) using relationships found in ResNet 6 database. Entrez official gene symbols are used for
protein names. (B) Example of how a relation between two groups (functional classes) is formed in the Atlas of Signaling. (C) Same pathway as in (A)
built with ontological groups: functional classes (orange hexagons) and cell process ‘‘actin-based cytoskeleton assembly’’ (yellow rectangle). The
description of relationships between entities on the pathways is provided in the legend to Table 2.
doi:10.1371/journal.pone.0009256.g001
Atlas of Signaling
PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9256Figure 2. Atlas of Signaling. The major known signaling cascades were combined in one pathway diagram to provide ‘‘birds-eye’’ view of cellular
signaling. Signaling functional groups are shown as orange hexagons; secondary messengers/small molecules–as green circles, and cellular
processes–as yellow rectangles.
doi:10.1371/journal.pone.0009256.g002
Table 2. Relation types on the Atlas of Signaling.
Relation type Description Count
ProtModification Protein members of the regulator class phosphorylate or otherwise modify proteins in the target class 243
DirectRegulation Protein members of one class bind and regulate proteins in another class 160
Binding Protein members of one class bind proteins in another class 18
PromoterBinding Protein members of one class bind promoters of genes encoding proteins in another class 8
Expression Protein members of one class regulate expression of proteins in another class 28
MolTransport Protein members of one class regulate export, import or release of proteins in another class 6
MolSynthesis Protein members of one class regulate level of proteins in another class or level of a small molecule/metabolite 12
ChemicalReaction Protein members of a class synthesize small molecule(s)/metabolite(s) 2
Regulation Protein members of one class indirectly regulate proteins in another class 384
doi:10.1371/journal.pone.0009256.t002
Atlas of Signaling
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groupsaredirectlyselected onthe‘‘AtlasofSignaling’’pathway
b. Individual signaling/regulatory proteins representing the
seeds of gene sets are first mapped to corresponding functional
groups by containment, which are then selected on the ‘‘Atlas
of Signaling’’ pathway.
All unmapped functional groups and cellular processes not
selected by this mapping procedure are then removed from the
Atlas of Signaling. The resulting ‘‘partial’’ pathway constitutes the
‘‘interpretation model’’ for a specific differential expression profile;
it contains classes of proteins whose members or ‘‘expression
targets’’ have revealed statistically significant changes in the
differential expression profile. Figure 3 illustrates the procedure of
sub-network generation and mapping the seeds of significant sub-
networks onto the Atlas of Signaling.
Results and Discussion
We have validated our approach by interpreting several publicly
available expression microarray experiments using the Atlas of
Signaling pathway. Since current focus of the Atlas is signal
transduction from surface receptors to transcription factors, we
have chosen experiments that measure response of normal human
tissues to different hormones.
We first analyzed GDS1036 experiment from NCBI GEO that
profiles gene expression in microglial cells in response to 200 u/ml
interferon-gamma (IFN-gamma). IFN-gamma is a soluble cytokine
and the only member of the type II class of interferons. In contrast
to interferon-alpha and interferon-beta, which can be expressed by
all cells, IFN-gamma is secreted only by T-lymphocytes, dendritic
cells and NK cells. Produced by lymphocytes activated by specific
antigens or mitogens, IFN-gamma, in addition to having antiviral
Figure 3. An overview of enrichment analysis and mapping onto the Atlas of Signaling. The ResNet gene expression regulatory network is
split into individual sub-networks around each protein. Each sub-network contains immediate downstream neighbors of an individual protein in the
network. In the depicted exemplary network, there are three sub-networks - build around ‘‘seed’’ proteins 1, 4 and 5; they are surrounded by dotted
lines. The projection to the Atlas of Signaling is done by selecting the functional groups on the Atlas containing the seed proteins of sub-networks
which were found to be statistically significant in the enrichment analysis. The three selected groups (rectangles) and relationships between them on
the Atlas are shown in solid lines. The remaining (un-involved) groups and relationships are shown by dotted lines.
doi:10.1371/journal.pone.0009256.g003
Atlas of Signaling
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activator of macrophages, it has anti-proliferative effects on trans-
formed cells, and it can potentiate the antiviral and antitumor
effects of the type I interferons.
The imported data set contained three time points: 1, 6, and
24 hours of IFN-gamma exposure. Data for each time point were
generated using microglial cell isolated from four different brain
specimens. Analysis of differential expression between untreated
samples and samples after 6 or 24 hours of exposure returned
very similar lists of differentially expressed genes. Therefore, for
further analysis, time points 6 and 24 hours were combined and
compared to corresponding untreated control samples. The
differential gene expression was calculated, followed by enrich-
ment analysis using Mann-Whitney test [6] against ‘‘expression
subnetwork’’ gene sets as described above. The significant sub-
networks (p,0.05) were mapped on the Atlas of Signaling and the
resulting pathway is shown on Figure 4. The majority of mapped
functional classes on the Atlas of Signaling formed a well-
connected sub-network with principal components being the
classical JAK-STAT pathway and interferon-response factors
(IRFs) that have been shown to be downstream of IFN-gamma
in numerous publications [7,8]. In addition, such cell processes as
prostaglandin synthesis, spindle assembly, lipid transport, and Ser/
Gly metabolism were also affected by IFN-gamma treatment in
microglial cells. Down-regulation of prostanoid production by
IFN-gamma has been shown previously [9]. Activation of spindle
assembly and Ser/Gly metabolism are indicative of cell prolifer-
ation that occurs upon microglia activation [10]. It was shown that
activated microglia export apolipoprotein E and J involved in lipid
transport [11]. Apolipoprotein E was linked to microglial
activation and to increased neurotoxicity in several publications
[12,13]. Our enrichment-mapping analysis also revealed all
components of tumor necrosis factor (TNF)-NF-kappa-B pathway
as significant. IFN-gamma-dependent production of TNF-alpha
mediated by STAT1 was previously reported [14]. Activation of
NF-kappa-B suggests activation of apoptosis in microglia that was
also documented previously [15]. Thus, TNF-alpha can also
provide a negative feedback loop to slow-down the spread of
microglia activated by IFN-gamma. One possible scenario is that
IFN-gamma induction activates microglia migration towards the
Figure 4. Projection of groups involved in IFN-gamma response in microglial cells onto Atlas of Signaling. The protein groups found by
projection of the results of enrichment analysis of GEO dataset GDS1036 were connected using existing relations in Atlas of Signaling. Group shapes
are as described in legend to Figure 2.
doi:10.1371/journal.pone.0009256.g004
Atlas of Signaling
PLoS ONE | www.plosone.org 6 February 2010 | Volume 5 | Issue 2 | e9256Figure 5. Projection of groups involved in TGF-beta response in lamina cribrosa cells onto Atlas of Signaling. (A) The protein groups found by
projection of the results of enrichment analysis of GEO dataset GDS1313 were connected using existing relations in the Atlas of Signaling. (B) Significant
groups not connected by direct relations from the Atlas were linked to the core network by adding minimal number of secondary messengers (green ovals)
and functional classes not significant according to enrichment results (highlighted in blue). Group shapes are as described in legend to Figure 2.
doi:10.1371/journal.pone.0009256.g005
Atlas of Signaling
PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9256Figure 6. Projection of groups involved in TNF-alpha response in microvascular endothelial cells onto Atlas of Signaling. GEO
dataset GDS1543 was analyzed as described in legend to Figure 5.
doi:10.1371/journal.pone.0009256.g006
Atlas of Signaling
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neurons, but also to initiate death of activated microglia in order to
stop the spread of inflammation beyond the site of injury.
Next, we analyzed the experiment GDS1313 which profiles the
response of the glial fibrillary acidic protein (GFAP)-negative
lamina cribrosa (LC) cells to a 24-hour exposure to Transforming
Growth Factor beta (TGF-beta) 1 at 10 ng/ml concentration.
TGF beta is a multifunctional protein that controls proliferation,
differentiation, and other functions in many cell types. Application
of the Transforming Growth Factors to normal rat kidney
fibroblasts induces proliferation in cultured cells that results in
overgrow that is no longer subjected to the normal cell-contact
inhibition. The GFAP-negative LC cells are used as a model for
primary open-angle glaucoma (POAG) when TGF-beta level is
elevated in human LC tissue. We have performed a similar
analytical workflow: differential gene expression followed by
enrichment analysis against ‘‘expression sub-network’’ gene sets
followed by mapping of significant sub-network seeds to the Atlas
of Signaling. The results of the analysis are shown on Figure 5. As
expected, the classical TGFbeta/SMAD pathway is identified as
significant along with the extracellular matrix proteins that are
directly regulated by SMADs. Involvement of extracellular matrix
(ECM) proteins identified by our analysis is in perfect agreement
with the fact that pathological hallmarks of the glaucomatous optic
nerve head include retinal ganglion cell axon loss and extracellular
matrix (ECM) remodeling of the lamina cribrosa layer [16].
Interestingly, the results also suggest involvement of p38 MAPK,
AKT and PKA pathways in the observed response which regulate
ECM deposition, cytoskeleton and focal junction assembly, protein
folding and several metabolic processes (Figure 5A). There is a
handful of unconnected protein classes (upper right corner of the
map), but they can be joined to the core network by a few
secondary messengers or functional classes whose expression was
not significantly affected by TGF-beta treatment (Figure 5B).
Finally, we have analyzed the experiment GDS1543 from
NCBI GEO repository measuring the effect of tumor necrosis
factor (TNF)-alpha on microvascular endothelial cells (HMEC)
(5 h, 2 ng/ml TNF). TNF-alpha is a cytokine involved in systemic
inflammation and is a member of a group of cytokines that
stimulate the acute phase reaction. It is mainly secreted by
macrophages and can induce cell death of certain tumor cell lines.
It is a potent pyrogen causing fever by direct action or by
stimulation of interleukin-1 secretion. Under certain conditions it
can stimulate cell proliferation and induce cell differentiation.
For the analysis, 2 samples (GSM50775 and GSM50773) were
excluded from the experiment because they have shown an
inconsistent clustering: they represent control and treatment
samples which clustered to each other as opposed to clustering
with other control and treatment samples. The pathway obtained
by mapping significant sub-network seeds on the Atlas of Signaling
is shown on Figure 6.
The universal feature of the TNF pathway conserved in
evolution and among different human tissues is believed to be
the activation of NF-kappa-B transcription factor [17]. Our
analysis has revealed an activation of NF-kappa-B in HMEC cells.
Nevertheless, TNF-alpha exhibits diverse effects on different
tissues [18,19]. The tissue specificity of TNF-alpha action is
determined by the tissue-specific expression of TNF receptor-
associated adaptors acting as scaffolds to associate different sets of
downstream signaling molecules with TNF-receptor in different
tissues, resulting in regulation of tissue-specific processes [20].
Gene expression analysis helps to select a particular set of such
target processes. For instance, our analysis revealed large number
of transport processes affected in HMEC cells by TNF-alpha
treatment. This can be a specific feature of endothelial cells. On
the other hand, membrane depolarization [21] and changes in cell
volume due to deregulation of ion homeostasis [22] is now
believed to play a pivotal role in early stages of apoptosis, which is
the main process regulated by NF-kappa-B.
In conclusion, we have developed a novel approach for a
systems-level interpretation of microarray expression data in the
context of manually constructed ‘‘overview’’ pathway depicting
the main cellular signaling channels. Using publicly available gene
expression datasets, we have demonstrated that the developed
approach can highlight the biologically plausible sub-networks of
the global cellular signaling network. We believe that the
developed approach can be used for general systems-level
interpretation of differential expression profiling experiments.
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